A New York federal judge on Tuesday declined to set aside a partial verdict for the state Attorney General's office against the Wisconsin-based makers of Prevagen, a significant order that affirms the AG's broad authority to investigate and regulate repeated acts of fraud.
Biotech & Pharmaceuticals
August 21, 2024, 2:18 PM